Hikma Pharmaceuticals PLC (HKMPF)
USD 26.2
(-0.02%)
USD 26.2
(-0.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 608 Million | 530 Million | 638 Million | 464 Million | 472 Million | 430 Million |
| Net Income | 281 Million | 233 Million | 544 Million | 558 Million | 491 Million | 293 Million |
| Depreciation & Amortization | 259 Million | 193 Million | 145 Million | 91 Million | 99 Million | 121 Million |
| Deferred income taxes | -125 Million | 135 Million | -89 Million | -26 Million | -99 Million | -57 Million |
| Stock-based compensation | 25 Million | 22 Million | 29 Million | 27 Million | 24 Million | 21 Million |
| Change in working capital | 80 Million | -131 Million | -30 Million | -208 Million | -44 Million | -25 Million |
| Other non-cash items | 88 Million | 78 Million | 39 Million | 22 Million | 1 Million | 77 Million |
| Investing Cash Flow | -333 Million | -607 Million | -238 Million | -283 Million | -151 Million | -96 Million |
| Investments in PPE | -204 Million | -225 Million | -229 Million | -224 Million | -186 Million | -139 Million |
| Acquisitions | -105 Million | -380 Million | -17 Million | -60 Million | 19 Million | 27 Million |
| Investment purchases | -27 Million | -15 Million | -3 Million | -5 Million | -6 Million | -4 Million |
| Sales/Maturities of investments | 1 Million | 87 Million | 6 Million | 2 Million | 14 Million | 4 Million |
| Other Investing Activities | 2 Million | -74 Million | 5 Million | 4 Million | 8 Million | 16 Million |
| Financing Cash Flow | -337 Million | -58 Million | -287 Million | -298 Million | -155 Million | -278 Million |
| Debt repayment | -1.3 Billion | -1.32 Billion | -476 Million | -1.73 Billion | -284 Million | -372 Million |
| Dividends payments | -140.3 Million | -122.72 Million | -117.94 Million | -116.19 Million | -100.72 Million | -84 Million |
| Common Stock Repurchased | - | -300 Million | - | -375 Million | - | - |
| Common Stock Issuance | - | 1.69 Billion | - | 1.92 Billion | - | - |
| Other Financing Activities | 1.1 Billion | -4 Million | 309 Million | -1 Million | 226 Million | 178 Million |
| Accounts receivables | -24.57 Million | 3.92 Million | -163.16 Million | -50.1 Million | 21.8 Million | -39.16 Million |
| Accounts payables | 90.12 Million | 15.7 Million | 13.76 Million | 6.39 Million | -6.23 Million | 84.05 Million |
| Inventory | -115 Million | -102 Million | 38 Million | -180 Million | -25 Million | -51 Million |
| Other working capital | 129.45 Million | -48.63 Million | 81.4 Million | 15.7 Million | -34.57 Million | -18.89 Million |
| Cash at beginning of period | 270 Million | 426 Million | 323 Million | 442 Million | 276 Million | 227 Million |
| Cash at end of period | 205 Million | 270 Million | 426 Million | 323 Million | 442 Million | 276 Million |
| Capital Expenditure | -204 Million | -225 Million | -229 Million | -224 Million | -186 Million | -139 Million |
| Effect of forex changes on cash | -3 Million | -21 Million | -10 Million | -2 Million | - | -7 Million |
| Net cash flow / Change in cash | -65 Million | -156 Million | 103 Million | -119 Million | 166 Million | 49 Million |
| Free Cash Flow | 404 Million | 305 Million | 409 Million | 240 Million | 286 Million | 291 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 226 Million | 281 Million | 59.94 Million | 134.83 Million | 233 Million | 15.44 Million |
| Depreciation & Amortization | 102 Million | 259 Million | 96.51 Million | 98.81 Million | 193 Million | 99.9 Million |
| Deferred income taxes | - | -125 Million | -126.67 Million | -340.4 Million | 135 Million | -199.21 Million |
| Stock-based compensation | 15 Million | 25 Million | 15 Million | 10 Million | 22 Million | 12 Million |
| Change in working capital | -223 Million | 80 Million | 199.99 Million | -118.36 Million | -131 Million | 370.41 Thousand |
| Other non-cash items | 78 Million | 88 Million | 104.72 Million | 406.57 Million | 78 Million | 416.98 Million |
| Investing Cash Flow | -106 Million | -333 Million | -219.48 Million | -125.57 Million | -607 Million | -155.19 Million |
| Investments in PPE | -69 Million | -204 Million | -96.79 Million | -110.13 Million | -225 Million | -120.69 Million |
| Acquisitions | -999.61 Thousand | -105 Million | -87.35 Million | -1.02 Million | -380 Million | -36.13 Million |
| Investment purchases | -1.99 Million | -27 Million | -22.26 Million | -5.14 Million | -15 Million | 1.34 Million |
| Sales/Maturities of investments | - | 1 Million | -16.33 Thousand | 1.02 Million | 87 Million | - |
| Other Investing Activities | -37 Million | 2 Million | -13.04 Million | -10.29 Million | -74 Million | 290.65 Thousand |
| Financing Cash Flow | -52 Million | -337 Million | -198.16 Million | -60.72 Million | -58 Million | -286.39 Million |
| Debt repayment | -47 Million | -1.3 Billion | -124.42 Million | -29.84 Million | -1.32 Billion | -201.68 Million |
| Dividends payments | -103.96 Million | -140.3 Million | -54.53 Million | -84.4 Million | -122.72 Million | -51.29 Million |
| Common Stock Repurchased | - | - | - | - | -300 Million | -26.26 Million |
| Common Stock Issuance | - | - | - | - | 1.69 Billion | -5.53 Million |
| Other Financing Activities | 5 Million | 1.1 Billion | -14.2 Million | -1.02 Million | -4 Million | -1.61 Million |
| Accounts receivables | -130 Million | -24.57 Million | 53.03 Million | -77.19 Million | 3.92 Million | 10.65 Million |
| Accounts payables | -23.99 Million | 90.12 Million | 56.37 Million | 32.93 Million | 15.7 Million | 34.2 Million |
| Inventory | -66 Million | -115 Million | -28.05 Million | -88.51 Million | -102 Million | -32.27 Million |
| Other working capital | -27 Million | 129.45 Million | 118.63 Million | 14.41 Million | -48.63 Million | -12.21 Million |
| Cash at beginning of period | 204.71 Million | 270 Million | 271.56 Million | 271.45 Million | 426 Million | 371.8 Million |
| Cash at end of period | 236 Million | 205 Million | 204.71 Million | 271.56 Million | 270 Million | 271.45 Million |
| Capital Expenditure | -69 Million | -204 Million | -96.79 Million | -110.13 Million | -225 Million | -120.69 Million |
| Effect of forex changes on cash | -9 Million | -3 Million | 1.29 Million | -3 Million | -21 Million | -12 Million |
| Net cash flow / Change in cash | 31.28 Million | -65 Million | -66.85 Million | 102.43 Thousand | -156 Million | -100.35 Million |
| Free Cash Flow | 129 Million | 404 Million | 252.69 Million | 81.31 Million | 305 Million | 224.78 Million |
SLXXF
0991
096530
ARTNB
TSKFF
3OY1